ADDENDUM
                                       TO
                       COMMERCIAL COGNOVIT PROMISSORY NOTE

THIS ADDENDUM TO COMMERCIAL COGNOVIT PROMISSORY NOTE ("Addendum") is made by and
between Wellstar  International,  Inc. and Trillennium Medical Imaging,  Inc., a
wholly owned  subsidiary  of Wellstar  International,  Inc.,  with its principal
office located at 6911 Pilliod Road, Holland, Ohio, 43528 ("Wellstar) and Andrew
M. Thompson,  an individual  residing at 1293 Prince Court, Lake Mary,  Florida,
32746 ("Thompson").

     In consideration of the covenants and agreements contained herein and other
good and  valuable  consideration,  the  receipt and  sufficiency  of which both
Wellstar  and Thompson  agree and  acknowledge,  Wellstar  and  Thompson  hereby
mutually agree as follows:

The Commercial Cognovit Promissory Note and all related documents evidencing the
loan from Thompson to Wellstar in the principal  amount of $400,000.00  dated on
or about  October 11,  2005  (collectively,  the "Note") are herby  collectively
amended to include and incorporate the following terms and conditions:

"Additional Conversion Restrictions.  In no event shall the Thompson be entitled
to convert the outstanding  principal  amount and accrued  interest of this Note
for shares of Common  Stock in excess of that  number of shares of Common  Stock
that, upon giving effect to such conversion, would cause the aggregate number of
shares of Common Stock  beneficially  owned by the Thompson and his "affiliates"
(as  defined  in Rule 405  under  the  Securities  Act) to  exceed  9.99% of the
outstanding   shares  of  the  Common  Stock  of  the  Wellstar  following  such
conversion.  For purposes of this  Paragraph the  aggregate  number of shares of
Common Stock beneficially owned by Thompson and his affiliates shall include the
number of shares of Common  Stock  issuable  upon  conversion  of this Note with
respect to which the  determination  is being made, but shall exclude the number
of shares of Common  Stock that would be  issuable  upon (i)  conversion  of any
remaining,  unconverted  portion of this Note and (ii) exercise or conversion of
the  unexercised  or  unconverted  portion of any other  Securities  (including,
without  limitation,  any  warrants)  subject to a limitation  on  conversion or
exercise  analogous to the limitation  contained  herein  beneficially  owned by
Thompson and his affiliates.  Except as set forth in the preceding sentence, for
purposes  of  this  Paragraph,  beneficial  ownership  shall  be  calculated  in
accordance  with  Section  13(d) of the  Securities  Exchange  Act of  1934,  as
amended.  For  purposes  of  this  Paragraph,   in  determining  the  number  of
outstanding  shares  of  Common  Stock  Thompson  may  rely  on  the  number  of
outstanding  shares of Common Stock as reflected in (1)  Wellstar's  most recent
Form  10-QSB  or Form  10-KSB,  as the case  may be,  (2) a more  recent  public
announcement  by  Wellstar or (3) any other  notice by Wellstar or its  transfer
agent  setting forth the number of shares of Common Stock  outstanding.  For any
reason at any time, upon the written or oral request of Thompson, Wellstar shall
immediately  confirm  orally and in writing to Thompson  the number of shares of
Common Stock then outstanding.  In any case, the number of outstanding shares of
Common Stock shall be determined  after giving effect to conversions of portions
of the Note by Thompson  since the date as of which such  number of  outstanding
shares of Common Stock was reported. To the extent that the limitation contained
in this Paragraph applies,  the determination of whether the Note is convertible
(in relation to other securities owned by Thompson) and of which portion of this
Note is convertible shall be made by Thompson, and the submission of a Notice of
Conversion shall be deemed to be Thompson's  determination that the Debenture is
convertible."

All other terms and conditions of the Note not  inconsistent  with the terms and
conditions hereof shall remain unaffected hereby and in full force and effect.

In Witness Whereof, Wellstar and Thompson have set their respective hands hereto
effective as of the date next following their respective signatures.

Wellstar International Inc., and
Trillennium Medical Imaging, Inc.,
a wholly owned subsidiary of Wellstar International, Inc.


By: /S/ John A. Antonio
   ---------------------
    John A. Antonio, President     Date: 11/10/06


Andrew M. Thompson


By: Andrew M. Thompson
   -------------------
    Andrew M. Thompson             Date: 11/10/06